Feed Top Reports Pricing

⌘K

00:15:18·1876d

SECFilingvia Quantisnow

SEC Form EFFECT filed

ByQuantisnow·Wall Street's wire, on your screen.

NOVS· Novus Capital Corporation

Finance

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NOVS (Novus Capital Corporation) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

NOVS
Novus Capital Corporation
Finance

Related

INSIDER1863d
SEC Form 4: J Robert Laikin sold $3,768,538 worth of Common Stock (162,500 units at $23.19), decreasing direct ownership by 37% to 276,635 units
13D/G1871d
SEC Form SC 13G filed
SEC1877d
SEC Form 424B3 filed
SEC1879d
SEC Form S-1/A filed
SEC1879d
SEC Form 8-K filed
SEC1879d
SEC Form 8-K/A filed
SEC1884d
SEC Form 8-K filed
13D/G1893d
SEC Form SC 13G filed

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022